Parliament Hears About Impediments To Investment
8th Aug 18
With the support of member businesses, ADIA has made recommendations to a parliamentary inquiry that will reduce the red-tape that frustrates the dental industry’s ability to invest in its growth.
Key Issues For The Dental Industry —
A parliamentary inquiry has been convened by the House of Representatives Standing Committee on Economics to review barriers to business investment.
After canvassing the views of its members, the Australian Dental Industry Association (ADIA) identified the fact that for members that manufacture and supply dental products, bureaucratic red-tape is the largest single barrier that the industry faces along with issues associated with electricity pricing and supply.
ADIA’s policy advocacy to support the members included the preparation of a submission which canvassed the following issues:
Medical Device Regulatory Reform ―
The need for the Therapeutic Goods Administration (TGA) to continue to streamline the regulatory framework for the manufacturing and supply of dental products. This will make it easier to introduce innovative products to the Australian marketplace through the increase reliance on overseas product standards and conformity assessment processes.
TGA Fees & Charges ―
The need for the Australian National Audit Office (ANAO) to undertake a review as to how it levies fees and charges on businesses to ensure that the regulator is not imposing an unnecessary compliance burden on businesses across the sector. This review would look at what TGA activities, such as patient education, should more appropriately be funded directly by the Australian Government rather than by industry.
Energy Pricing ―
The Australian Government, and its state/territory counterparts, should coordinate reform to reduce electricity prices and enhance reliability of the electricity supply.
The parliamentary inquiry invited ADIA to give evidence at a hearing which afforded the opportunity to reinforce the salient points set out in its submission, a copy of which can be downloaded below.
Participation in Parliamentary Committees like these is one of the key mechanisms that ADIA uses to ensure that the views of member businesses help influence the national debate.
ADIA will continue to liaise with the House of Representatives Standing Committee on Economics as it undertakes its inquiry to ensure that its recommendations support the ability of businesses in the dental industry to invest.
Member Engagement —
ADIA provides leadership, strategy, advocacy, and support. Our members set our agenda, fund our activities, and directly benefit from the results. With respect to the Association's work to support businesses in the dental industry the team in the ADIA national office receive advice and guidance from members serving on the ADIA-TCPC Trade & Commercial Policy Committee.
Further Information —
For further information on ADIA's advocacy to make it easier to invest in your business, please send an email to firstname.lastname@example.org or telephone 1300 943 094. To keep up to date follow ADIA on Facebook at www.facebook.com/dental.industry or subscribe to the Twitter feed @AusDental.
Currency Of Information & Disclaimer —
This update was issued on 7 August 2018 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, images and where stated.
8th May 18
Local manufacturers and importers of dental laboratory products are being urged to step-up and meet their legal obligations by reporting their activities to the Therapeutic Goods Administration (TGA).
3rd May 18
Proposals from the Australian Government to impose new cost imposts on suppliers of low-risk medical devices will eliminate the entire benefit of its tax cuts for many small businesses in Australia’s dental industry.